Benzinga's Volume Movers

MannKind MNKD shares moved up 11.30% to $11.13. The volume of MannKind shares traded was 784% higher than normal. MannKind jumped following the conditional FDA approval for Afrezzaa. Dicerna Pharmaceuticals DRNA shares rose 14.92% to $21.65. The volume of Dicerna Pharmaceuticals shares traded was 545% higher than normal. Dicerna Pharma jumped on promising clinical data for DCR-PH1 Flamel Technologies SA FLML surged 5.75% to $14.87. The volume of Flamel Technologies shares traded 350% higher than normal. Flamel Tech announced the FDA approval of VAZCULEP. GW Pharmaceuticals plc GWPH shares climbed 7.51% to $103.36. The volume of GW Pharmaceuticals shares traded was 280% higher than normal. Piper Jaffray raised the price target on GW Pharma from $97 to $147.